CHMP recommends SC Rybrevant for EGFR-mutated NSCLC patients

3rd February 2025 Uncategorised 0

Positive opinion issued for marketing authorisation extension

More: CHMP recommends SC Rybrevant for EGFR-mutated NSCLC patients
Source: News